Gelonghui November 24 | According to the latest equity disclosure data from the Stock Exchange, on November 22, 2023, Changmao Biotech (00954.HK) received an increase of 304,000 shares at an average price of HK$0.5368 per share, involving approximately HK$163,200, by executive director Rui Xinsheng (Chairman).
After increasing its holdings, the latest number of shares held by Rui Xinsheng was 6.032 million shares, and the shareholding ratio increased from 3.12% to 3.28%.
